Mobile electrocardiography (mECG) devices can go places a standard 12-lead electrocardiography system can't, with fewer technicians in tow, but it doesn't have the same functionality — their most ...
Perhaps 40% of persons with genetically confirmed long-QT syndrome (LQTS) do not show the telltale electrocardiographic (ECG) feature, a prolonged heart-rate-corrected QT (QTc) interval, when their 12 ...
AliveCor is also offering a service called InstantQT™ to assist in measuring QT intervals through an FDA-cleared, ECG processing software. The Food and Drug Administration (FDA) has cleared the ...
An asymptomatic male patient with definite LQTS with a normal ECG and QTc who was flagged by the AI. Photo Credit: J. Martijn Bos and Michael Ackerman. A new artificial intelligence (AI) solution ...
This cohort study assessed ECG parameters in transgender men and women before and after use of gender-affirming hormone therapies. Testosterone use in transgender men was associated with shorter ...
Please provide your email address to receive an email when new articles are posted on . AliveCor announced it received FDA 510(k) clearance for its mobile, handheld ECG device for the calculation of a ...
AUSTIN, TX—Controversy surrounds the issue of methadone-induced QTc-interval prolongation (QTcP or torsades de pointes), and just who should have EKG testing and when. According to study results ...
In allogeneic HSCT, a therapeutic effect generally follows provision of normal, ordered, donor-derived hematopoiesis after successful engraftment of hematopoietic stem cells. Patients undergo pre-HSCT ...
Researchers from Mayo Clinic and AliveCor Inc. have been using artificial intelligence (AI) to develop a mobile device that can identify certain patients at risk of sudden cardiac death. This research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results